HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of evidence for the presence of neutrophil autoantibodies in the serum of patients with Felty's syndrome.

Abstract
Sera of 22 patients with Felty's syndrome and 14 patients with rheumatoid arthritis were tested in assays routinely used for the detection of neutrophil antibodies (i.e. immunofluorescence, agglutination and cytotoxicity tests) as well as in the antibody-dependent lymphocyte-mediated granulocytotoxicity test. One or more of the routinely used assays were positive in a high percentage of the sera (77% and 64%, respectively). The antibody-dependent lymphocyte-mediated granulocytotoxicity test was only positive with sera of three patients with Felty's syndrome. Positive results in the immunofluorescence and agglutination tests could be attributed to the presence of immune complexes in the sera, whereas positive antibody-dependent lymphocyte-mediated granulocytotoxicity tests were probably due to the presence of HLA alloantibodies. It is concluded that serological tests routinely used for the detection of neutrophil autoantibodies should be interpreted with caution in patients with Felty's syndrome. Our results also indicate that the neutropenia in Felty's syndrome is rarely, if ever, due to neutrophil-specific autoantibodies.
AuthorsR Goldschmeding, F C Breedveld, C P Engelfriet, A E von dem Borne
JournalBritish journal of haematology (Br J Haematol) Vol. 68 Issue 1 Pg. 37-40 (Jan 1988) ISSN: 0007-1048 [Print] England
PMID3345294 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Autoantibodies
Topics
  • Arthritis, Rheumatoid (immunology)
  • Autoantibodies (analysis)
  • Felty Syndrome (immunology)
  • Humans
  • Immunologic Tests
  • Neutrophils (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: